Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for ''
published presentations and documents on DocSlides.
Medicines Session Medicines Information Medicines
by edwin
Basic enquiry answering. September . 2016. Session...
Access to affordable and quality assured essential medicines
by ellena-manuel
Gilles Forte. Policy. , Access and Use Team. Depa...
EU Trade policy & Access to Medicines
by mitsue-stanley
Stops AIDS National Gathering . 1st November 2014...
Workshop on IP & Access to Medicines at
by min-jolicoeur
Cochin University of Science & Technology . S...
Barriers to access to innovative medicines
by ameer
Dr. Richard Torbett. Chief Economist, EFPIA. Chin...
Short Update WHO Essential Medicines and Health products
by jane-oiler
IPC Meeting . 4 to 6 . June. 2014. Essential Med...
Short Update WHO Essential Medicines and Health products
by natalia-silvester
IPC Meeting . 4 to 6 . June. 2014. Essential Med...
Access to essential medicines
by marina-yarberry
for asthma. WHO . Technical. Briefing . Seminar....
Access to essential medicines
by conchita-marotz
for asthma. WHO . Technical. Briefing . Seminar....
Access to essential medicines
by min-jolicoeur
for asthma. WHO . Technical. Briefing . Seminar....
WHO EMP update for IPC June 2016
by conchita-marotz
Access to medicines and technologies. Report . to...
WHO EMP update for IPC June 2016
by lindy-dunigan
Access to medicines and technologies. Report . to...
WHO EMP update for IPC June 2016
by tatyana-admore
Access to medicines and technologies. Report . to...
Universal Health Coverage
by min-jolicoeur
:. . Considerations . in Designing Medicines Ben...
Designing and Managing
by lois-ondreau
Medicines Benefits – . Goals, Policy Options, E...
WHO Essential Medicines and Health Products
by min-jolicoeur
Strategic Plan Development – . Feed-back from t...
SafeScript Training Acknowledgement of country
by liane-varnes
I would like to acknowledge the traditional custo...
WHO Essential Medicines and Health Products
by conchita-marotz
Strategic Plan Development – . Feed-back from t...
Medicines Adaptive Pathways to Patients (MAPPs):
by debby-jeon
Saving Time, Saving Lives. Thursday, 4 June 2015,...
NHS West Lancashire CCG – Strategy, Vision & Operational Update
by calandra-battersby
Paul Kingan, Chief Finance Officer. 112,000 popul...
Improving access to medicines through local production:
by luanne-stotts
Some New Development. I P C Meeting, Copenhagen (...
Pharmaceuticals
by kittie-lecroy
and Global Health: Successes, Challenges and . Ou...
Innovation and Access:
by myesha-ticknor
Intersection . of Public Health and Intellectual ...
Improving access to medicines through local production:
by aaron
Some New Development. I P C Meeting, Copenhagen (...
Innovation and Access:
by marina-yarberry
Intersection . of Public Health and Intellectual ...
Improving access to medicines through local production:
by phoebe-click
Some New Development. I P C Meeting, Copenhagen (...
Competition Law/Policy and the Consequences for Access and Innovation for Medicines/Healthcare
by eleanor
Globalising Asia: Health Law, Governance, and Poli...
TIF.ACCESS Programme: Guidance and Best Practices for Patient Associations
by rodriguez
Eleni Antoniou. Senior Policy Officer. Thalassaemi...
IP & Access to Medicines
by debby-jeon
Round Table, EPIP 2017, Bordeaux. Chirantan Chatt...
How Advocacy can Influence Pricing &
by mia
P. olicy. Jessica Burry. HIV/HCV Pharmacist. July ...
1 TRIPS and Public Health: Implications for the Pharmaceutical Sector in Africa
by lindy-dunigan
Update on Pharmaceutical . Manufacturing Plan for...
Antimicrobial resistance (AMR) –
by min-jolicoeur
a pharmaceutical industry perspective. 17. th. N...
International IP Regime
by mitsue-stanley
. and A2M . : Role of BRICS. K M Gopakumar . TWN...
Load More...
